Inventor
VANDERMEEREN MARC
BE16 patents
⚠️ This page may combine multiple inventors who share the name “VANDERMEEREN MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNOGENETICS NV
8 patentsUS6238892B1May 29, 2001
Monoclonal antibodies directed against the microtubule-associated protein tau
INNOGENETICS NV84 citations97
US6010913AJan 4, 2000
Isolated human tau peptide
INNOGENETICS NV36 citations95
US5843779ADec 1, 1998
Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
INNOGENETICS NV51 citations95
US6900293B2May 31, 2005
Monoclonal antibodies directed against the microtubule-associated protein tau
INNOGENETICS NV14 citations92
US6500674B1Dec 31, 2002
Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
INNOGENETICS NV20 citations92
US6232437B1May 15, 2001
Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.
INNOGENETICS NV25 citations92
US6008024ADec 28, 1999
Monoclonal antibodies specific for PHF-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
INNOGENETICS NV32 citations92
US5861257AJan 19, 1999
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
INNOGENETICS NV21 citations92
JANSSEN BIOTECH INC
4 patentsUS9371376B2Jun 21, 2016
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC10 citations80
US10196440B2Feb 5, 2019
Anti-PHG-tau antibodies and their uses
JANSSEN BIOTECH INC3 citations71
US10000559B2Jun 19, 2018
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC2 citations71
US9745371B2Aug 29, 2017
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC1 citations60
JANSSEN PHARMACEUTICA NV
3 patentsUS10851156B2Dec 1, 2020
Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies
JANSSEN PHARMACEUTICA NV8 citations80
US10519223B2Dec 31, 2019
Antibodies to pyroglutamate amyloid-β and uses thereof
JANSSEN PHARMACEUTICA NV5 citations80
US11673943B2Jun 13, 2023
Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof
JANSSEN PHARMACEUTICA NV0 citations58